The biotech sector witnessed a see-saw performance in 2024. While the year started on a positive note, much of the gains ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ...